Clinical trial

Multicenter Selective Lymphadenectomy Trial (MSLT)

NCT00275496 · Saint John's Cancer Institute, Other · Completed

Key facts

NCT number NCT00275496
Title Multicenter Selective Lymphadenectomy Trial (MSLT)
Official title A Clinical Study of Wide Excision Alone Versus Wide Excision With Intraoperative Lymphatic Mapping and Selective Lymph Node Dissection in the Treatment of Patients With Cutaneous Invasive Melanoma.
Lead sponsor Saint John's Cancer Institute, Other
Collaborators National Institutes of Health (NIH) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Melanoma
Intervention type Procedure
Interventions Sentinel Lymph Node Dissection, Complete Lymph Node Dissection, Wide Excision
Enrollment 2,001
Start date Nov 1, 1993
Primary completion Jun 1, 2012
Completion Jun 1, 2012
First posted Jan 12, 2006
Last update posted Sep 2, 2015

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies